Try our Advanced Search for more refined results
January 12, 2017
Amgen Inc. v. Sanofi
Case Number:
17-1480
Court:
Nature of Suit:
830 Patent Infringement (Fed. Question)
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 23, 2018
Amgen Denied Full Fed. Circ. Hearing On Repatha Patents
The full Federal Circuit will not review a panel decision that revived a challenge to Amgen's patents for Repatha, an antibody-based cholesterol treatment, according to a decision issued by the appeals court Friday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login